Plus500 Ltd.

LSE:PLUS Stock Report

Market Cap: UK£1.8b

Plus500 Valuation

Is PLUS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PLUS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PLUS (£24.2) is trading below our estimate of fair value (£56.52)

Significantly Below Fair Value: PLUS is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PLUS?

Key metric: As PLUS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PLUS. This is calculated by dividing PLUS's market cap by their current earnings.
What is PLUS's PE Ratio?
PE Ratio8.2x
EarningsUS$273.70m
Market CapUS$2.25b

Price to Earnings Ratio vs Peers

How does PLUS's PE Ratio compare to its peers?

The above table shows the PE ratio for PLUS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18.2x
TCAP TP ICAP Group
19.5x21.5%UK£1.9b
AJB AJ Bell
23.4x7.4%UK£1.9b
IGG IG Group Holdings
10.7x6.0%UK£3.3b
CMCX CMC Markets
19.3x15.0%UK£904.8m
PLUS Plus500
8.2x-0.09%UK£1.8b

Price-To-Earnings vs Peers: PLUS is good value based on its Price-To-Earnings Ratio (8.2x) compared to the peer average (18.2x).

Price to Earnings Ratio vs Industry

How does PLUS's PE Ratio compare vs other companies in the GB Capital Markets Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PNIX Phoenix Digital Assets
1.1xn/aUS$32.25m
IX. i(x) Net Zero
0.1xn/aUS$8.94m
APQ APQ Global
0.4xn/aUS$5.78m
No more companies available in this PE range
PLUS 8.2xIndustry Avg. 12.1xNo. of Companies16PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PLUS is good value based on its Price-To-Earnings Ratio (8.2x) compared to the UK Capital Markets industry average (12.1x).

Price to Earnings Ratio vs Fair Ratio

What is PLUS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PLUS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8.2x
Fair PE Ratio14.2x

Price-To-Earnings vs Fair Ratio: PLUS is good value based on its Price-To-Earnings Ratio (8.2x) compared to the estimated Fair Price-To-Earnings Ratio (14.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PLUS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£24.20
UK£28.47
+17.6%
5.0%UK£30.34UK£26.49n/a4
Nov ’25UK£23.72
UK£28.47
+20.0%
5.0%UK£30.34UK£26.49n/a4
Oct ’25UK£24.92
UK£25.95
+4.1%
18.3%UK£29.63UK£17.87n/a4
Sep ’25UK£25.92
UK£25.34
-2.2%
17.7%UK£30.16UK£18.18n/a4
Aug ’25UK£23.52
UK£24.64
+4.8%
15.8%UK£30.45UK£18.57n/a5
Jul ’25UK£22.58
UK£24.67
+9.2%
15.9%UK£30.44UK£18.74n/a5
Jun ’25UK£22.36
UK£24.67
+10.3%
15.9%UK£30.44UK£18.74n/a5
May ’25UK£21.80
UK£25.17
+15.5%
15.2%UK£30.55UK£19.23n/a5
Apr ’25UK£18.05
UK£24.28
+34.5%
16.2%UK£30.38UK£18.80n/a5
Mar ’25UK£17.33
UK£24.28
+40.1%
16.2%UK£30.38UK£18.80n/a5
Feb ’25UK£17.69
UK£23.70
+34.0%
21.0%UK£30.57UK£15.54n/a5
Jan ’25UK£16.63
UK£23.05
+38.6%
21.8%UK£30.40UK£16.20n/a4
Dec ’24UK£14.74
UK£23.05
+56.4%
21.8%UK£30.40UK£16.20n/a4
Nov ’24UK£14.21
UK£23.05
+62.2%
21.8%UK£30.40UK£16.20UK£23.724
Oct ’24UK£13.77
UK£23.23
+68.7%
27.1%UK£31.62UK£13.85UK£24.924
Sep ’24UK£14.27
UK£22.30
+56.3%
27.5%UK£30.42UK£13.14UK£25.924
Aug ’24UK£14.85
UK£22.34
+50.4%
28.5%UK£30.91UK£12.96UK£23.524
Jul ’24UK£14.65
UK£22.27
+52.0%
28.5%UK£31.09UK£13.17UK£22.584
Jun ’24UK£14.61
UK£22.50
+54.0%
27.7%UK£31.01UK£13.40UK£22.364
May ’24UK£16.65
UK£22.50
+35.2%
27.7%UK£31.01UK£13.40UK£21.804
Apr ’24UK£16.92
UK£22.68
+34.0%
27.2%UK£31.24UK£13.82UK£18.054
Mar ’24UK£18.03
UK£22.68
+25.8%
27.2%UK£31.24UK£13.82UK£17.334
Feb ’24UK£18.68
UK£21.44
+14.8%
30.3%UK£31.03UK£13.44UK£17.694
Jan ’24UK£18.04
UK£22.42
+24.3%
26.6%UK£31.34UK£14.86UK£16.634
Dec ’23UK£19.32
UK£22.42
+16.0%
26.6%UK£31.34UK£14.86UK£14.744
Nov ’23UK£18.45
UK£22.42
+21.5%
26.6%UK£31.34UK£14.86UK£14.214

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

BFF Bank

€1.6b

Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.

0RON

€8.43

7D

-7.0%

1Y

-14.9%

HAL Trust

€10.3b

Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.

0K9V

€114.20

7D

-0.3%

1Y

2.3%

Wendel

€3.9b

A private equity firm specializing in equity financing in middle markets and later stages through leveraged buy-out and transactions and acquisitions.

0HZD

€93.22

7D

1.5%

1Y

25.7%